ALPHE.PA - Pherecydes Pharma So...

Discounted Cash Flow Model of Pherecydes Pharma Société anonyme(ALPHE.PA), Pherecydes Pharma SA develops antibacterial treatments based on the use of bacteriophage viruses or

Pherecydes Pharma Société anonyme

ALPHE.PA

EURONEXT

Inactive Equity

Pherecydes Pharma SA develops antibacterial treatments based on the use of bacteriophage viruses or phages. It develops a portfolio of therapeutics, such as anti-Staphylococcus aureusphages for the treatment of bone/joint and diabetic foot ulcer infections; anti-Pseudomonas aeruginosa phages for the treatment of complicated urinary tract infections; and anti-Escherichia coli phages for the treatment of respiratory tract infections. The company was founded in 2006 and is based in Romainville, France.

2 EUR

-0.01 (-0.5%)

Overview Profile Financial Statements Financial Ratios Chart Analysis News Corporate Actions DCF

FMP

Home Terms of Service Privacy Policy Blog Contact Us

API

Documentation Pricing Formulas Market Indexes

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.